Log in
Enquire now
InterVenn Biosciences

InterVenn Biosciences

InterVenn is a medical diagnostics company developing artificially intelligence driven mass spectrometry platform for discovery and validation.

OverviewStructured DataIssuesContributors

Contents

intervenn.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biology
Biology
Biotechnology
Biotechnology
Medical diagnostics
Medical diagnostics
Engineering
Engineering
Proteomics
Proteomics
Biomedical engineering
Biomedical engineering
Technology
Technology
Location
‌
Redwood City, California, United States
San Bruno, California
San Bruno, California
Redwood City, California
Redwood City, California
Kuala Lumpur
Kuala Lumpur
Philippines
Philippines
South San Francisco, California
South San Francisco, California
Mandaluyong
Mandaluyong
Fitzroy, Victoria
Fitzroy, Victoria
...
B2X
B2C
B2C
B2B
B2B
0
CEO
Aldo Carrascoso
Aldo Carrascoso
Founder
Aldo Carrascoso
Aldo Carrascoso
‌
Lieza Danan
Carlito Lebrilla
Carlito Lebrilla
Carolyn R. Bertozzi
Carolyn R. Bertozzi
Pitchbook URL
pitchbook.com/profiles...225669-61
Legal Name
Venn Biosciences Corp
Accelerator
Boost VC
Boost VC
Legal classification
Corporation
Corporation
Date Incorporated
2017
Number of Employees (Ranges)
51 – 200
Email Address
info@venn.bio
partnerships@venn.bio
joinus@venn.bio
Phone Number
+18666561888
+18887061670
Number of Employees
1660
Full Address
L3-E-11 Enterprise 4, Technology Park Malaysia, Lebuhraya Puchong -Sg. Bukit Jalil. 57000, Kuala Lumpur, Malaysia
19th Floor, The Podium West Tower, 12 ADB Avenue, Ortigas Center, Mandaluyong City 1550, Philippines
Level 2 , 91-93 Victoria Parade, Fitzroy, Melbourne, VIC 3065, Australia
2 TOWER PLACE, 5TH FLOOR SOUTH SAN FRANCISCO CA 94080
CIK Number
1,756,172
Place of Incorporation
Delaware
Delaware
Investors
Boost VC
Boost VC
Genoa Ventures
Genoa Ventures
True Ventures
True Ventures
‌
Matadero Capital
Prado SV
Prado SV
Amplify Partners
Amplify Partners
Xeraya Capital
Xeraya Capital
...
Founded Date
2017
0
Total Funding Amount (USD)
250,900,000
Latest Funding Round Date
August 2, 2021
Competitors
Iconic Therapeutics
Iconic Therapeutics
Opsani
Opsani
Also Known As
InterVenn Biosciences
Latest Funding Type
Series C
Series C
Patents Assigned (Count)
1
Country
United States
United States

Other attributes

Blog
intervenn.bio/blog
Company Operating Status
Active
Latest Funding Round Amount (USD)
201,000,000

InterVenn Biosciences offers a product pipeline that features glycoproteomic laboratory diagnostic tests based on liquid biopsies (blood samples) using serum or plasma, combining the molecular-level resolution of mass spectrometry with the throughput of artificial intelligence.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like InterVenn Biosciences

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.